지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2022.1
- 수록면
- 81 - 92 (12page)
- DOI
- 10.4093/dmj.2021.0016
이용수
초록· 키워드
오류제보하기
Background: To evaluate the effects of teneligliptin on glycosylated hemoglobin (HbA1c) levels, continuous glucose monitoring (CGM)-derived time in range, and glycemic variability in elderly type 2 diabetes mellitus patients.Methods: This randomized, double-blinded, placebo-controlled study was conducted in eight centers in Korea (clinical trial registration number: NCT03508323). Sixty-five participants aged ≥65 years, who were treatment-naive or had been treated with stable doses of metformin, were randomized at a 1:1 ratio to receive 20 mg of teneligliptin (n=35) or placebo (n=30) for 12 weeks. The main endpoints were the changes in HbA1c levels from baseline to week 12, CGM metrics-derived time in range, and glycemic variability.Results: After 12 weeks, a significant reduction (by 0.84%) in HbA1c levels was observed in the teneligliptin group compared to that in the placebo group (by 0.08%), with a between-group least squares mean difference of ?0.76% (95% confidence interval [CI], ?1.08 to ?0.44). The coefficient of variation, standard deviation, and mean amplitude of glycemic excursion significantly decreased in participants treated with teneligliptin as compared to those in the placebo group. Teneligliptin treatment significantly decreased the time spent above 180 or 250 mg/dL, respectively, without increasing the time spent below 70 mg/dL. The mean percentage of time for which glucose levels remained in the 70 to 180 mg/dL time in range (TIR70?180) at week 12 was 82.0%±16.0% in the teneligliptin group, and placebo-adjusted change in TIR70?180 from baseline was 13.3% (95% CI, 6.0 to 20.6).Conclusion: Teneligliptin effectively reduced HbA1c levels, time spent above the target range, and glycemic variability, without increasing hypoglycemia in our study population.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Effect of Teneligliptin versus Sulfonylurea on Major Adverse Cardiovascular Outcomes in People with Type 2 Diabetes Mellitus: A Real-World Study in Korea
Endocrinology and Metabolism
2021 .01
-
1,5-Anhydroglucitol as a Useful Marker for Assessing Short-Term Glycemic Excursions in Type 1 Diabetes
Diabetes and Metabolism Journal
2015 .01
-
Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study
Diabetes and Metabolism Journal
2021 .01
-
Glucose Profiles Assessed by Intermittently Scanned Continuous Glucose Monitoring System during the Perioperative Period of Metabolic Surgery
Diabetes and Metabolism Journal
2022 .09
-
Determinants of Long-Term Durable Glycemic Control in New-Onset Type 2 Diabetes Mellitus
Diabetes and Metabolism Journal
2017 .01
-
Glycemic Control Is Associated with Histological Findings of Nonalcoholic Fatty Liver Disease
Diabetes and Metabolism Journal
2024 .05
-
Impact of Social Distancing Due to Coronavirus Disease 2019 on the Changes in Glycosylated Hemoglobin Level in People with Type 2 Diabetes Mellitus
Diabetes and Metabolism Journal
2021 .01
-
Long-Term Changes in HbA1c According to Blood Glucose Control Status During the First 3 Months After Visiting a Tertiary University Hospital
Journal of Korean Medical Science
2022 .10
-
Personality Traits Do Not Have Influence on Glycemic Control in Outpatients with Type 2 Diabetes Mellitus
PSYCHIATRY INVESTIGATION
2020 .01
-
Clinical Implications of Glucose Variability: Chronic Complications of Diabetes
Endocrinology and Metabolism
2015 .01
-
Long-Term Risk of Cardiovascular Disease Among Type 2 Diabetes Patients According to Average and Visit-to-Visit Variations of HbA1c Levels During the First 3 Years of Diabetes Diagnosis
Journal of Korean Medical Science
2023 .01
-
Subjective Assessment of Diabetes Self-Care Correlates with Perceived Glycemic Control but not with Actual Glycemic Control
Diabetes and Metabolism Journal
2015 .01
-
Improvement of Glycosylated Hemoglobin in Patients with Type 2 Diabetes Mellitus under Insulin Treatment by Reimbursement for Self-Monitoring of Blood Glucose
Diabetes and Metabolism Journal
2018 .01
-
Glycated albumin may have a complementary role to glycated hemoglobin in glucose monitoring in childhood acute leukemia
Annals of Pediatirc Endocrinology & Metabolism
2024 .08
-
How Can We Easily Measure Glycemic Variability in Diabetes Mellitus?
Diabetes and Metabolism Journal
2015 .01
-
당뇨병환자에서 혈당조절의 목표
대한의사협회지
2017 .01
-
Year-Long Trend in Glycated Hemoglobin Levels in Patients with Type 2 Diabetes during the COVID-19 Pandemic
Endocrinology and Metabolism
2021 .10
-
Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
Diabetes and Metabolism Journal
2019 .01
-
Efficacy and safety of Panax ginseng berry extract on glycemic control : A 12-wk randomized, double-blind, and placebo-controlled clinical trial
Journal of Ginseng Research
2018 .01
-
제2형 당뇨병 환자의 혈당조절 영향요인 분석: 제7기 국민건강영양조사자료(2016~2018) 이용
Health & Nursing
2021 .11
이 논문의 저자 정보
최근 본 자료
댓글(0)
0